CSN Login
Members Online: 17

5-Alpha reductase inhibitors in patients on active surveillance: Do the benefits outweigh the risk? - Abstract

hopeful and opt...
Posts: 1282
Joined: Apr 2009

5-Alpha reductase inhibitors in patients on active surveillance: Do the benefits outweigh the risk? - Abstract

 

Prostate cancer (PCa) is a slow, progressive disease.

Prostate specific antigen testing, screening, and aggressive case identification has made PCa the most frequently diagnosed cancer. Concerns regarding overdiagnosis and overtreatment flourish on a large scale. In order to avoid overtreatment for those in whom therapeutic intervention is not required, active surveillance for eligible patients with the use of 5-alpha reductase can be considered a safe and a promising approach to delay the progression of the disease with minimal side effects.

Written by: 
Al Edwan G, Fleshner N.   Are you the author? 
Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada. Ghazi.aledwan@uhn.ca

Reference: Curr Urol Rep. 2013 Apr 12. Epub ahead of print. 
doi: 10.1007/s11934-013-0324-y

PubMed Abstract
PMID: 23579402

UroToday.com Prostate Cancer Section

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network